Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 259

Sort by

Sort Order Select

Journal Articles

Development of the Lee Symptom Scale–Skin Sclerosis for chronic GVHD–associated sclerosis

Emily Baumrin, Joseph Pidala, Sandra A. Mitchell, Lynn Onstad, Stephanie J. Lee

Blood (2025) 145 (12): 1321–1332.

https://doi.org/10.1182/blood.2024027334

Published: 2025

Includes: Supplemental data

Journal Articles

Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

Blood blood.2024027543.

https://doi.org/10.1182/blood.2024027543

Published: 2025

Includes: Supplemental data

Journal Articles

FDA-approved therapies for chronic GVHD

Stephanie J. Lee, Robert Zeiser

Blood (2025) 145 (8): 795–800.

https://doi.org/10.1182/blood.2024026633

Published: 2025

Journal Articles

Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease

Julie R Boiko, Kathleen S. Ensbey, Olivia G Waltner, Isaac C Jenkins, Shruti S Bhise, Kelli PA MacDonald, Bruce R Blazar, Anne Marcie Hall, Ted A Gooley, Simone A Minnie, Stephanie J. Lee, Scott N Furlan, Geoffrey R Hill

Blood blood.2024025337.

https://doi.org/10.1182/blood.2024025337

Published: 2025

Includes: Supplemental data

Journal Articles

Biomarker Dynamics in Pediatric Transplantation-Associated Thrombotic Microangiopathy (TA-TMA): A Prospective Cohort and Nested Case-Control Study

Shengling Ma, Saleh Bhar, Pavan Bhatraju, Mrinal Ranjan, Danielle Guffey, Maria Elizabeth Morales, Christopher I Amos, Caridad Martinez, Stephanie J. Lee, Sangeeta Hingorani, Sarah E Sartain, Ang Li

Blood (2024) 144 (Supplement 1): 688.

https://doi.org/10.1182/blood-2024-202173

Published: 2024

Journal Articles

Dynamics of Overall and Organ-Specific Responses to Axatilimab in Chronic Graft-Versus-Host Disease: Analysis from the Agave-201 Study

Hannah Choe, Amandeep Salhotra, Nosha Farhadfar, Mi Kwon, Britnie Thomas, Vedran Radojcic, Chuan Tian, Shuyuan Lou, Daniel Wolff, Stephanie J. Lee

Blood (2024) 144 (Supplement 1): 98.

https://doi.org/10.1182/blood-2024-209965

Published: 2024

Journal Articles

Fecal Microbiota Transplantation to Prevent Acute Graft-Versus-Host Disease: First Pre-Planned Interim Analysis of a Randomized Trial

Armin Rashidi, Swetha Reddi, Maryam Ebadi, Liliia Senyshyn, Amanda Kabage, Samuel Minot, Ted Gooley, Stephanie J. Lee, Geoffrey R. Hill, Alexander Khoruts

Blood (2024) 144 (Supplement 1): 2149.

https://doi.org/10.1182/blood-2024-202112

Published: 2024

Journal Articles

Likelihood of finding an 8/8 HLA-matched unrelated donor (Donor Search Prognosis) is not associated with survival: Primary results from BMT CTN 1702

Blood (2024) 144 (Supplement 1): 695.

https://doi.org/10.1182/blood-2024-200833

Published: 2024

Journal Articles

Factors Associated with Early Quality of Life Response to Palliative Care during Hematopoietic Cell Transplantation

Richard Newcomb, Hermioni L Amonoo, Alison R Kavanaugh, James Fausto, Jason A Webb, Joseph A Greer, Jennifer S Temel, Porsha Lark, Dustin J Rabideau, Thomas W. LeBlanc, Stephanie J. Lee, Areej El-Jawahri

Blood (2024) 144 (Supplement 1): 5056.

https://doi.org/10.1182/blood-2024-207178

Published: 2024

Journal Articles

Quality of Life during Survivorship Following Autologous Stem Cell Transplant for Mantle Cell Lymphoma

Mengyang Di, Carrie I Ho, Stephen D. Smith, Mazyar Shadman, Chaitra S. Ujjani, Ryan C. Lynch, Christina Poh, Vikram Raghunathan, Brian G. Till, Edus H. Warren, Ajay K. Gopal, Stephanie J. Lee

Blood (2024) 144 (Supplement 1): 5116.

https://doi.org/10.1182/blood-2024-201827

Published: 2024

Journal Articles

Cytokines associated with organ manifestations in chronic graft-versus-host disease

Stephanie J. Lee, Ningxin Ma, Timothy Randolph, Carrie L. Kitko, Corey S. Cutler, Najla El Jurdi, George Chen, Betty K. Hamilton, Joseph A. Pidala, Paul A Carpenter, Sally Arai, Lynn Onstad, Sophie Paczesny, Tomoko Sekiguchi, Motoko Koyama, Geoffrey R. Hill

Blood (2024) 144 (Supplement 1): 4902.

https://doi.org/10.1182/blood-2024-203743

Published: 2024

Journal Articles

Pre-Transplant Patient-Reported Outcomes Are Associated with Health Care Utilization and Transplant-Related Complications at One-Year Post-Transplant

Anna Barata, Richard Newcomb, Patrick Connor Johnson, Ella Caruso, Porsha Lark, Emelia J. Farnam, Thomas W. LeBlanc, Stephanie J. Lee, Areej El-Jawahri

Blood (2024) 144 (Supplement 1): 2330.

https://doi.org/10.1182/blood-2024-202065

Published: 2024

Journal Articles

Financial Toxicity and Time Toxicity in Multiple Myeloma: Prevalence, Predictors, and Impact on QOL

Rahul Banerjee, Andrew J. Cowan, Marivel Chavez-Ortega, Paul A Carpenter, Masumi Ueda Oshima, Rachel B. Salit, Phuong T Vo, Catherine J. Lee, Rohtesh S. Mehta, Nicole M. Kuderer, Veena Shankaran, Stephanie J. Lee, Christopher T. Su

Blood (2023) 142 (Supplement 1): 2386.

https://doi.org/10.1182/blood-2023-174554

Published: 2023

Journal Articles

Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study

Robert Zeiser, Domenico Russo, Ron Ram, Shahrukh K Hashmi, Ronjon Chakraverty, Jan Moritz Middeke, Maurizio Musso, Sebastian Giebel, Ant Uzay, Peter Langmuir, Nada Hamad, Xuechan Li, Maanasa Gowda, Tommaso Stefanelli, Stephanie J. Lee, Takanori Teshima, Franco Locatelli

Blood (2023) 142 (Supplement 1): 654.

https://doi.org/10.1182/blood-2023-172590

Published: 2023

Journal Articles

Combined Effect of Unrelated Donor Age and HLA Peptide-Binding Motifs (PBM) Match Status on HCT Outcomes

Rohtesh S. Mehta, Effie W. Petersdorf, Stephen R. Spellman, Stephanie J. Lee

Blood (2023) 142 (Supplement 1): 1045.

https://doi.org/10.1182/blood-2023-173887

Published: 2023

Journal Articles

Allogeneic Hematopoietic Cell Transplantation in the 7 th Decade of Life and Beyond

Mary-Elizabeth M. Percival, Ted Gooley, Chris Davis, Ryan S. Basom, Stephanie J. Lee, Frederick R. Appelbaum, Mohamed Sorror

Blood (2023) 142 (Supplement 1): 3608.

https://doi.org/10.1182/blood-2023-185037

Published: 2023

Journal Articles

Donor Hematopoietic Cell Telomere Length and Magnitude of Post-HCT Shortening Predict Survival in Early Stage Leukemia and Myelodysplastic Syndrome

Shahinaz M. Gadalla, Hormuzd Katki, Tsung-Po Lai, Casey Dagnall, Caitrin Bupp, Amy Hutchinson, James Anderson, Kyra Mendez, Stephen R. Spellman, Valerie Stewart, Sharon Savage, Stephanie J. Lee, John Levine, Wael Saber, Abraham Aviv

Blood (2023) 142 (Supplement 1): 365.

https://doi.org/10.1182/blood-2023-189396

Published: 2023

Journal Articles

Late CMV Disease after Hematopoietic Cell Transplantation: Significance of Post-Transplant Cyclophosphamide, Steroid Treatment and CMV Viral Load

Alicja Sadowska-Klasa, Sezen Ozkok, Hu Xie, Wendy Leisenring, Danniel Zamora, Sachiko Seo, Jordan Sheldon, Stephanie J. Lee, Margaret L Green, Michael Boeckh

Blood (2023) 142 (Supplement 1): 3583.

https://doi.org/10.1182/blood-2023-180305

Published: 2023

Journal Articles

Coping in Patients with Hematologic Malignancies Undergoing Hematopoietic Cell Transplantation

Richard Newcomb, Hermioni L Amonoo, Ashley M Nelson, Joanna Choe, Katherine Holmbeck, Anisa Nably, Stephanie J. Lee, Thomas W LeBlanc, Areej El-Jawahri

Blood (2023) 142 (Supplement 1): 2424.

https://doi.org/10.1182/blood-2023-179471

Published: 2023

Journal Articles

HLA-DRB1 Hed Is Associated with Improved Survival and Decreased Relapse in Patients with Hematologic Malignancies Following Allogeneic Hematopoietic Stem Cell Transplant

Christine Camacho-Bydume, Tao Wang, Diego Chowell, Chirag Krishna, Brian C. Shaffer, Steven Marsh, Sophie Paczesny, Shahinaz M. Gadalla, Meilun He, Yung-Tsi Bolon, Stephen R. Spellman, Stephanie J. Lee, Katharine C. Hsu

Blood (2023) 142 (Supplement 1): 2232.

https://doi.org/10.1182/blood-2023-179543

Published: 2023

NARROW

Development of the Lee Symptom Scale–Skin Sclerosis for chronic GVHD–associated sclerosis

Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

FDA-approved therapies for chronic GVHD

Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease

Biomarker Dynamics in Pediatric Transplantation-Associated Thrombotic Microangiopathy (TA-TMA): A Prospective Cohort and Nested Case-Control Study

Dynamics of Overall and Organ-Specific Responses to Axatilimab in Chronic Graft-Versus-Host Disease: Analysis from the Agave-201 Study

Fecal Microbiota Transplantation to Prevent Acute Graft-Versus-Host Disease: First Pre-Planned Interim Analysis of a Randomized Trial

Likelihood of finding an 8/8 HLA-matched unrelated donor (Donor Search Prognosis) is not associated with survival: Primary results from BMT CTN 1702

Factors Associated with Early Quality of Life Response to Palliative Care during Hematopoietic Cell Transplantation

Quality of Life during Survivorship Following Autologous Stem Cell Transplant for Mantle Cell Lymphoma

Cytokines associated with organ manifestations in chronic graft-versus-host disease

Pre-Transplant Patient-Reported Outcomes Are Associated with Health Care Utilization and Transplant-Related Complications at One-Year Post-Transplant

Financial Toxicity and Time Toxicity in Multiple Myeloma: Prevalence, Predictors, and Impact on QOL

Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study

Combined Effect of Unrelated Donor Age and HLA Peptide-Binding Motifs (PBM) Match Status on HCT Outcomes

Allogeneic Hematopoietic Cell Transplantation in the 7 th Decade of Life and Beyond

Donor Hematopoietic Cell Telomere Length and Magnitude of Post-HCT Shortening Predict Survival in Early Stage Leukemia and Myelodysplastic Syndrome

Late CMV Disease after Hematopoietic Cell Transplantation: Significance of Post-Transplant Cyclophosphamide, Steroid Treatment and CMV Viral Load

Coping in Patients with Hematologic Malignancies Undergoing Hematopoietic Cell Transplantation

HLA-DRB1 Hed Is Associated with Improved Survival and Decreased Relapse in Patients with Hematologic Malignancies Following Allogeneic Hematopoietic Stem Cell Transplant

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only